Cencora, a global healthcare leader, has introduced Accelerate Pharmacy Solutions, a comprehensive suite of services aimed at helping hospital and health system customers streamline operations and improve financial performance. This new portfolio consolidates Cencora’s pharmacy and supply chain solutions, providing…
VSee Health, Inc. (Nasdaq: VSEE), a leader in telehealth solutions known for its scalable technology and clinical expertise, has partnered with AbundaBox to launch AbundaLife™, an innovative health record management platform. AbundaLife addresses the challenge of fragmented medical records by…
BostonGene, a leader in AI-driven molecular and immune profiling solutions, has announced that 10 of its abstracts have been selected for poster presentations, and two will be featured for online publication at the 66th American Society of Hematology (ASH) Annual…
Parse Biosciences, a leader in accessible and scalable single-cell sequencing solutions, has announced the creation of the world’s largest single-cell dataset to date, comprising 100 million cells. This milestone was achieved in just one month using Parse Biosciences’ GigaLab platform,…
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced that its Decipher Prostate Genomic Classifier is now the only gene expression test included in version 1 of the 2025 NCCN® Clinical Practice Guidelines in Oncology (NCCN Guidelines®). It is…
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a major milestone, surpassing 1,000 placements of its EZ2 Connect automated sample preparation instrument, a key advancement in the EZ1 instrument line. Launched in 2021, the EZ2 Connect has quickly become…
Lyra Health, a leader in innovative Workforce Mental Health solutions for employers and health plans, is excited to announce that Jennifer Schulz will join the company as Chief Executive Officer and Board member, effective January 13, 2025. Schulz will succeed…
Exai Bio, a leading RNA- and AI-based liquid biopsy company, has announced the appointment of Karen E. Knudsen, MBA, PhD, to its board of directors. Knudsen, the former CEO of the American Cancer Society (ACS) and its affiliate, the American…
Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, has announced the launch of the SHORTEN-ctDNA clinical trial at Columbia University. The study aims to assess the use of Foresight CLARITY™ MRD detection for real-time treatment optimization…
Presidio Medical, Inc., a clinical-stage company focused on developing a groundbreaking neuromodulation platform, is excited to announce the appointment of Richard J. Buchholz to its Board of Directors. Rick currently serves as the Chief Financial Officer at Inspire Medical Systems,…
University Medical Devices (UMD), a leader in healthcare technology innovation, has announced the launch of its first specimen collection solution, MicroWash. Developed at the onset of the COVID-19 pandemic, MicroWash offers a comfortable and highly sensitive nasal lavage collection method,…
OnMed, a leading tech-enabled hybrid care company, is set to debut its innovative OnMed CareStation at CES 2025 in Las Vegas, Nevada. This breakthrough solution is transforming how underserved communities access essential healthcare, positioning OnMed as a pioneer in closing…